# Boston Scientific closes acquisition of Symetis for $435M

Boston Scientific completed its acquisition of Symetis SA, a Swiss TAVI device company, for $435 million in cash, expanding its structural heart portfolio.

- Type: Acquisition
- Announced: 2017-06-03
- Where: Switzerland
- Value: $435.0M
- Status: completed
- Products: transcatheter aortic valve implantation devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Boston Scientific](https://endata.com/companies/15966.md) (acquirer)
- [Symetis SA](https://endata.com/companies/23188.md) (target)

## Sources

- [jdsupra.com](https://www.jdsupra.com/legalnews/boston-scientific-closes-acquisition-of-77616/), 2017-06-03: "The acquisition expands Boston Scientific’s structural heart portfolio and Symetis will join the Boston Scientific Interventional Cardiology division."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.